Tag: Ozempic
-
GLP-1 Drugs May Skew PET-CT Scans: A Hidden Risk for Cancer Detection
Understanding the emerging imaging challenge with GLP-1 medications GLP-1 receptor agonists, including popular drugs like Ozempic, Wegovy, and Mounjaro, have transformed weight loss and diabetes management. Yet as usage surged—reported to have risen about 700% in the United States from 2019 to 2023—so have reports of unusual side effects. A less obvious consequence is their…
-
Wegovy and Ozempic: Could Semaglutide Help Alcohol Dependence?
The new front in addiction research: GLP-1 drugs and alcohol Semaglutide, the active ingredient in Wegovy (weight loss) and Ozempic (diabetes), is being explored beyond its approved uses. Anecdotal reports have noted that some people on these injections drink less alcohol, prompting researchers to study whether semaglutide could help those struggling with alcohol dependence. A…
-
Wegovy and Ozempic Could Help Alcohol Dependence: Early Findings
Background Wegovy and Ozempic are brand names for semaglutide, a GLP‑1 receptor agonist. While they are primarily used for obesity management and type 2 diabetes, researchers are beginning to explore whether these drugs might influence alcohol use disorders as well. In a small US study, investigators observed that some participants reduced their alcohol consumption while…
-
Semaglutide Could Aid Alcohol Dependence: Wegovy & Ozempic
New clues on semaglutide and alcohol dependence In recent years, semaglutide, the active ingredient in Wegovy and Ozempic, has drawn attention beyond weight loss and diabetes management. A small American study provides the first clinical hints that this GLP-1 receptor agonist could help people with alcohol use disorder by reducing the amount they drink during…
-
Berberine and Weight Loss: The Truth Behind Nature’s Ozempic
Introduction In recent years, Berberine has emerged in the health and wellness community as a promising supplement for weight loss, earning it the nickname “nature’s Ozempic.” This compound, found in several plants like barberry and goldenseal, has shown potential for helping individuals manage their weight and improve metabolic health. But what is the truth behind…
-
Bariatric Surgery vs. Ozempic: Complementary Treatments for Obesity
Understanding Obesity Treatments: Bariatric Surgery and Ozempic As obesity rates continue to climb globally, effective treatments are more important than ever. Among the options available, bariatric surgery and medications like Ozempic have gained significant attention. However, many misconceptions suggest these two treatments compete, rather than complement each other. This article delves into both options, their…
-
Understanding Bariatric Surgery and Ozempic: Complementary Treatments for Obesity
Introduction to Obesity Treatments Obesity is a growing health concern worldwide, affecting millions of individuals and leading to various physical and mental health complications. With the rise of obesity, treatments have evolved significantly over the years. Two prominent approaches to managing obesity are bariatric surgery and the use of weight loss medications such as Ozempic.…
-
Understanding Bariatric Surgery and Ozempic: A Balanced Approach
Introduction The rise of weight loss medications like Ozempic has sparked discussions about their role in obesity treatment compared to traditional methods, particularly bariatric surgery. While both approaches aim to combat obesity, they serve different purposes and target distinct audiences. Here, we delve into the differences between bariatric surgery and Ozempic, clarifying misconceptions and outlining…
-
Understanding the Controversy Surrounding Ozempic Use in Ireland
Introduction to Ozempic and Its Use Ozempic, known generically as semaglutide, is a medication primarily prescribed for type 2 diabetes management. However, its off-label use for weight loss has raised eyebrows and sparked significant controversy across various communities, particularly in Ireland. The Financial Impact on the HSE In 2024, the Health Service Executive (HSE) revealed…
-
Ozempic Costs Taxpayers Millions: A Deep Dive
The Financial Impact of Ozempic in Ireland In 2024, the Health Service Executive (HSE) revealed that a staggering 41 million Euro was spent on the controversial weight loss drug, Ozempic. This expenditure falls under the long-term illness scheme and primarily benefits medical card holders. As discussions continue about the drug’s efficacy and cost, it is…